DEXRAZOXANE FOR INJECTION 500 MG
DEXRAZOXANE : 500 MG · DIN 02544091 · JUNO PHARMACEUTICALS CORP.
Health Canada status: CANCELLED PRE MARKET
What is DEXRAZOXANE FOR INJECTION?
DEXRAZOXANE FOR INJECTION 500 MG contains DEXRAZOXANE : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02544091, held by JUNO PHARMACEUTICALS CORP., supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled pre market, status dated 29-Jul-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02544091 |
|---|---|
| Brand name | DEXRAZOXANE FOR INJECTION |
| Generic / active ingredient | DEXRAZOXANE : 500 MG |
| Manufacturer | JUNO PHARMACEUTICALS CORP. |
| Strength | 500 MG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | V03AF02 DEXRAZOXANE |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 29-Jul-2026 |
Is DEXRAZOXANE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by JUNO PHARMA CANADA INC., last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code V03AF02 DEXRAZOXANE. 3 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DEXRAZOXANE FOR INJECTION | 250 MG | POWDER FOR SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | DIN 02544083 |
| DEXRAZOXANE FOR INJECTION | 250 MG | POWDER FOR SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02557649 |
| ZINECARD | 250 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02153432 |
| ZINECARD | 500 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | DORMANT | DIN 02153440 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.